HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Zhandong Zhou Robert D. Lasley Robert M. Mentzer, Jr. Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, Z. Articles by Mentzer, R. M. Search for Related Content PubMed PubMed Citation Articles by Zhou, Z. Articles by Mentzer, R. M., Jr.

J Thorac Cardiovasc Surg 1995;110:1391-1401
© 1995 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

MYOCARDIAL STUNNING: A THERAPEUTIC CONUNDRUM

Madison, Wis., and Bethesda, Md.

Address for reprints: Robert M. Mentzer, Jr., MD, Chairman, Division of Cardiothoracic Surgery, University of Wisconsin—Madison, Clinical Science Center, H4/358, 600 Highland Ave., Madison, WI 53792.

Abstract

Dobutamine and pyruvate are two inotropic agents with different mechanisms of action. Although both agents alter postischemic myocardial dysfunction, their potential metabolic effects in the setting of in vivo myocardial stunning have not been addressed. In this study, the effects of dobutamine and pyruvate on systolic wall thickening, myocardial phosphorylation potential index, interstitial fluid adenosine level, and myocardial oxygen consumption in in vivo stunned porcine myocardium were assessed. Stunning was induced with a 10-minute occlusion of the left anterior descending coronary artery. After 30 minutes of reperfusion, pigs were treated with either intravenous dobutamine (10 µg/kg per minute) or intracoronary pyruvate (1 ml/min, 150 mmol/L solution, pH 7.4). Infusion of both agents resulted in a marked improvement in regional systolic wall thickening. The dobutamine effect, however, produced a marked increase in myocardial oxygen consumption and was associated with an increase in interstitial adenosine caused by myocardial de-energization, because the myocardial phosphorylation potential index ratio decreased from 0.17 ± 0.02 to 0.09 ± 0.02 (p <0.05). In contrast, pyruvate enhanced myocardial energy status, because the myocardial phosphorylation potential index ratio increased from 0.20 ± 0.03 to 0.55 ± 0.08 (p <0.01). These experimental findings suggest that under certain circumstances the use of ß-receptor agonists to treat myocardial stunning may be suboptimal, if not undesirable. Further investigation is warranted to determine the optimum therapy for the stunned heart. (J THORAC CARDIOVASC SURG 1995;110:1391-1401)

This article has been cited by other articles:

				F. A. Oliveira, S. Guatimosim, C. H. Castro, D. T. Galan, S. Lauton-Santos, A. M. Ribeiro, A. P. Almeida, and J. S. Cruz Abolition of reperfusion-induced arrhythmias in hearts from thiamine-deficient rats Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H394 - H401. [Abstract] [Full Text] [PDF]

				E. M. Knott, M.-G. Ryou, J. Sun, A. Heymann, A. B. Sharma, Y. Lei, M. Baig, R. T. Mallet, and A. H. Olivencia-Yurvati Pyruvate-fortified cardioplegia suppresses oxidative stress and enhances phosphorylation potential of arrested myocardium Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1123 - H1130. [Abstract] [Full Text] [PDF]

				R. T. Mallet, J. Sun, E. M. Knott, A. B. Sharma, and A. H. Olivencia-Yurvati Metabolic Cardioprotection by Pyruvate: Recent Progress Experimental Biology and Medicine, July 1, 2005; 230(7): 435 - 443. [Abstract] [Full Text] [PDF]

				G. Kristo, Y. Yoshimura, J. Niu, B. J. Keith, R. M. Mentzer Jr., R. Bunger, and R. D. Lasley The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H517 - H524. [Abstract] [Full Text] [PDF]

				J. M. Smith and C. F. Pilati Effect of Massive Sympathetic Nervous System Activation on Coronary Blood Flow and Myocardial Energy Pool Experimental Biology and Medicine, February 1, 2002; 227(2): 125 - 132. [Abstract] [Full Text] [PDF]

				K. D. Yi, H. F. Downey, X. Bian, M. Fu, and R. T. Mallet Dobutamine enhances both contractile function and energy reserves in hypoperfused canine right ventricle Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2975 - H2985. [Abstract] [Full Text] [PDF]

				R. T. Mallet Pyruvate: Metabolic Protector of Cardiac Performance Experimental Biology and Medicine, February 1, 2000; 223(2): 136 - 148. [Abstract] [Full Text]

				R. T Mallet and J. Sun Mitochondrial metabolism of pyruvate is required for its enhancement of cardiac function and energetics Cardiovasc Res, April 1, 1999; 42(1): 149 - 161. [Abstract] [Full Text] [PDF]

				B. J. Martin, H. H. Valdivia, R. Bunger, R. D. Lasley, and R. M. Mentzer Jr. Pyruvate augments calcium transients and cell shortening in rat ventricular myocytes Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H8 - H17. [Abstract] [Full Text] [PDF]